VGX-3100 HPV Cancer Vaccine — Vax-Before-Travel

VGX-3100 HPV Cancer Vaccine

Fact checked by Robert Carlson, MD

Jan 7

4 min read

HPV Treatment Demonstrates Positive Phase 2 Efficacy When Treating Precancerous Vulvar Dysplasia

INOVIO VGX-3100 demonstrated clinically significant reduction of HPV-16/18 associated precancerous vulvar lesions

women holding hands looking hopeful

Fact checked by Robert Carlson, MD

Aug 19

3 min read

HPV 16 Immunotherapy Study Completes Patient Enrollment

Inovio Pharmaceuticals VGX-3100 immunotherapy targets human papillomavirus (HPV) 16 and 18

mountain with a person celebrating on the top of it

Sexually Transmitted Diseases

Fact checked by Danielle Reiter, RN

Jul 9

4 min read

VGX-3100 Cancer Immunotherapy Ready to Launch HPV Phase 2 Study

Inovio Pharmaceuticals VGX-3100 is a DNA-based cancer immunotherapy for the treatment of HPV 16 & 18 infection and precancerous lesions of the cervix, vulva, and anus

women soccer players

Sexually Transmitted Diseases

Fact checked by Robert Carlson, MD

Jun 26

5 min read

REVEAL 1 Cervical Cancer Study Ready to Launch

Inovio Pharmaceutical VGX-3100 vaccine is for the treatment of HPV related cervical pre-cancer

people around a camp fire celebrating

Cervical Cancer

Fact checked by Robert Carlson, MD

Apr 17

3 min read

VGX-3100 Named Best Therapeutic Vaccine Candidate for HPV

Invovio VGX-3100 immunotherapy utilizes the patient's own immune system to clear human papillomavirus infections

young couple sitting on the end of a dock talking at night

Sexually Transmitted Diseases